Companies / AMS

ATOMOS LIMITED

ASX:AMSConsumer Durables & Apparel
1.49B shares on issueASX (delayed) · as of 28 July 2026$0.008price · delayed$13.4Mmarket cap · indicative
C
Dilution grade

Runway under 2 quarters; share count grew 23% in 24 months; 9% of shares in the money

Cash runway0.6 quarters of funding
Share-count growth (24m)22.6%
Raise cadence (24m)0 cash raises
Options & rights overhang10.0% of shares
In-the-money supply8.8% of shares
Pending proposed issuesnone

ATOMOS LIMITED's ordinary share count rose 22.6% between May 2024 and April 2026, to 1.49B shares. The company did not raise capital in that 24-month window. Options and rights on issue could convert into 149M new shares, equal to 10.0% of the current share count, of which 9% are in the money at the current share price; the nearest expiry is June 2030. At the March 2026 quarter the company reported A$1.9M in cash, equivalent to 0.6 quarters of funding at its recent spending rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
10.0%
Max option dilution
8.8%
ITM option dilution
0
Raises · last 12 months
0.6 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 1.49B per ASX (delayed) (28 July 2026).
1.27B1.35B1.43BDec 24Sept 25July 26

Cash runway

—
Cover not computed for the latest quarter.
$1.9M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
30 Apr 20262A · quoted issueAMS : ORDINARY FULLY PAID1.49BAppendix 2A
7 Dec 20252A · quoted issueAMS : ORDINARY FULLY PAID1.48BAppendix 2A
2 Dec 20253G · unquotedAMS : ORDINARY FULLY PAID1.22BAppendix 3G
2 Dec 20252A · quoted issueAMS : ORDINARY FULLY PAID1.25BAppendix 2A
28 Nov 20252A · quoted issueAMS : ORDINARY FULLY PAID1.42BAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

10.0%
Total overhang · of current shares
8.8%
In the money · at current price
149.4M
Potential new shares
June 2030
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
28 Nov 2025Peter Gordon BarberBuy100.0M100.0M$3.0M3Y notice
24 Nov 2025James JoughinOther1.6M1.6M$48k3Y notice
20 Nov 2025Peter Gordon BarberOther1.6M16.1M$46k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

24 July 2026Atomos response to media reporting
6 July 2026$PFY26 Trading Update
30 Apr 2026Section 708A Cleansing Statement
30 Apr 2026Application for quotation of securities - AMS
30 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
29 Apr 2026NAB 2026 Product and Ecosystem Update
26 Apr 2026Completion of Flanders Scientific acquisition
13 Apr 2026Proposed issue of securities - AMS
12 Apr 2026$PAtomos to Acquire Flanders Scientific
9 Apr 2026$PNew Finance Facility
5 Mar 2026Company Secretary Appointment/Resignation
4 Mar 2026Change in substantial holding - clarification
4 Mar 2026Change in substantial holding - clarification
4 Mar 2026Change in substantial holding - clarification
1 Mar 2026New Product Release - Ninja RAW
26 Feb 2026$PAppendix 4D and HY Report to 31 December 2025
13 Feb 2026New Product Release - Shogun AV-19
11 Feb 2026Investor Presentation
26 Jan 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
7 Dec 2025Application for quotation of securities - AMS

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.